Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04850196
Other study ID # TEAS and POCD
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date December 1, 2022
Est. completion date April 10, 2024

Study information

Verified date April 2022
Source Shengjing Hospital
Contact Junchao Zhu
Phone +8618940257257
Email zhujunchao1@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Elderly patients are often considered as a high-risk population for major abdominal surgery due to reduced functional reserve and increased comorbidities. Previous study reported that about 40 and 10% of elderly (60 yr and older) patients suffered from postoperative cognitive dysfunction (POCD) 7 days and 3 months, respectively, after noncardiac surgery. POCD is a central nervous system complication after anesthesia and an operation, whose risk factors include age, education level, the operation (time, type, and mode), anesthesia (methods, drugs, and time) and postoperative analgesia. In the study of Su X et al, elderly patients are also more prone to develop postoperative sleep disturbances after surgery with prolonged sleep latencies, fragmented sleep, decreased sleep efficiency and abnormally sleep stages. Increasing evidence showed that sleep and circadian rhythm disturbances after surgery could promote β-amyloid peptide (Aβ) accumulation by simultaneously upregulating Aβ synthesis and interfering with Aβ clearance. This insoluble Aβ aggregates to form brain extracellular senile plaques, which are one of the neuropathological hallmarks of numerous postoperative cognitive disorders such as Alzheimer's disease(AD), and can be measured by amyloid positron emission tomography (PET) imaging through injecting 18F-florbetapir, a novel imaging agent that binds with high affinity (Kd 3.1 nM+0.7) to β-amyloid peptide fibrils in brain amyloid plaques, to the patients.Transcutaneous electrical acupoint stimulation (TEAS) is a new acupuncture therapy developed by combining transcutaneous electrical nerve stimulation (TENS) in European and American countries and traditional Chinese acupuncture. TEAS treat disease through inputting a pulse current of different frequencies, intensities, and waveforms via electrode paste adhering to the skin. Previous studies proved that TEAS has been successfully applied in many different procedures through stimulating different acupoints such as reducing postoperative pain, postoperative nausea and vomiting (PONV), and improving postoperative sleep quality. However, whether TEAS could affect Aβ deposition by improving postoperative sleep quality and thus affect the development of long-term cognitive impairment is still unclear. The aim of our study is to conduct the TEAS intervention to elderly patients who received laparoscopic abdominal surgery, and then to examine its effect on postoperative sleep quality, postoperative cognition and complications. In this study, we utilized 18F-florbetapir imaging to assess the relationships between postoperative sleep disturbances and POCD and brain Aβ burden through measuring by PET imaging.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date April 10, 2024
Est. primary completion date March 30, 2024
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: - patient's age was 65 yr or older - patient was scheduled to undergo elective major laparoscopic abdominal surgery (e.g., gastrointestinal and gynecologic surgery). - the surgery was expected to last 2h or longer. Exclusion Criteria: - severe diseases in cardiovascular, respiratory, liver, kidney, or central nervous systems and having a life span of less than 3 months; - a mini-mental status examination score (MMSE) of less than 23; - a history of dementia or psychiatric illness; - current use of sedatives, antidepressants or corticosteroids; - alcoholism and drug dependence; - difficulty with follow-up or poor compliance; - patients with preoperative sleep disturbances; - patients with sleep apnea or moderate and severe obstructive sleep apnea-hypopnea syndrome (OSAHS); - patients with severe visual or hearing impairment or who were unable to communicate.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
TEAS
TEAS treatment was performed for 30 mins before anesthesia on bilateral side by an experienced acupuncturist at the Neiguan (PC6), HT7 (Shenmen), ST36 (Zusanli) and LI4 (Hegu) acupoints . And TEAS treatment for 30 mins was also performed on bilateral side by an experienced acupuncturist at the Neiguan (PC6), HT7 (Shenmen), ST36 (Zusanli) and LI4 (Hegu) acupoints at the end of surgery as well as on the each night before sleeping after surgery until discharged from the hospital
Other:
control group
Patients in the Control group received electrical stimulation at a non-acupoint which was located 2 cm interior to the bilateral Neiguan (PC6), HT7 (Shenmen), ST36 (Zusanli) and LI4 (Hegu) acupoints similar to patients in group TEAS

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Shengjing Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Sleep Quality Assessment use the Athens Insomnia Scale (AIS): the total AIS scores range from 0 to 24 points with = 4 indicating no combined with insomnia at night; 4-6 indicating suspicious insomnia at night; = 6 points indicating a diagnosis of insomnia at night on the first night before surgery (Preop 1)
Primary Sleep Quality Assessment use the Athens Insomnia Scale (AIS): the total AIS scores range from 0 to 24 points with = 4 indicating no combined with insomnia at night; 4-6 indicating suspicious insomnia at night; = 6 points indicating a diagnosis of insomnia at night the third night after surgery (POD 3).
Primary Sleep Quality Assessment use the Athens Insomnia Scale (AIS): the total AIS scores range from 0 to 24 points with = 4 indicating no combined with insomnia at night; 4-6 indicating suspicious insomnia at night; = 6 points indicating a diagnosis of insomnia at night the first week after surgery (POD 1W).
Primary Sleep Quality Assessment use the Athens Insomnia Scale (AIS): the total AIS scores range from 0 to 24 points with = 4 indicating no combined with insomnia at night; 4-6 indicating suspicious insomnia at night; = 6 points indicating a diagnosis of insomnia at night the sixth months after surgery (POD 6M).
Primary Cognitive Assessment MMSE is a 30-point questionnaire that is widely used to evaluate the severity of cognitive impairment in individuals with cognitive disorders. Score cutoffs for the MMSE are as follows: greater than or equal to 24 for normal cognition, between 19 and 23 for MCI, between 10 and 18 for moderate cognitive impairment, and less than or equal to 9 for severe cognitive impairment. on the first night before surgery (Preop 1)
Primary Cognitive Assessment MMSE is a 30-point questionnaire that is widely used to evaluate the severity of cognitive impairment in individuals with cognitive disorders. Score cutoffs for the MMSE are as follows: greater than or equal to 24 for normal cognition, between 19 and 23 for MCI, between 10 and 18 for moderate cognitive impairment, and less than or equal to 9 for severe cognitive impairment. the third night after surgery (POD 3).
Primary Cognitive Assessment MMSE is a 30-point questionnaire that is widely used to evaluate the severity of cognitive impairment in individuals with cognitive disorders. Score cutoffs for the MMSE are as follows: greater than or equal to 24 for normal cognition, between 19 and 23 for MCI, between 10 and 18 for moderate cognitive impairment, and less than or equal to 9 for severe cognitive impairment. the first week after surgery ( POD 1W)
Primary Cognitive Assessment MMSE is a 30-point questionnaire that is widely used to evaluate the severity of cognitive impairment in individuals with cognitive disorders. Score cutoffs for the MMSE are as follows: greater than or equal to 24 for normal cognition, between 19 and 23 for MCI, between 10 and 18 for moderate cognitive impairment, and less than or equal to 9 for severe cognitive impairment. the sixth month after surgery (POD 6M).
Primary Aßburden PET imaging participants were injected intravenously with fluorine 18-labeled florbetaben tracer (Neuraceq; Piramel Imaging), and imaging was performed approximately 60 minutes later as per a standard protocol using PET-computed tomography. Aß PET imaging was performed on the first week after surgery ( POD 1W)
Primary Aßburden PET imaging participants were injected intravenously with fluorine 18-labeled florbetaben tracer (Neuraceq; Piramel Imaging), and imaging was performed approximately 60 minutes later as per a standard protocol using PET-computed tomography. Aß PET imaging was performed on the sixth month after surgery (POD 6M).
Secondary Postoperative pain assessment pain scores were assessed on the visual analogue scale (VAS), where 0 indicates painlessness, and 10 indicates severe pain. The VAS score was measured at 2, 4, 6, and 24 hours postoperatively. 24 hours after surgery
Secondary Postoperative adverse effects assessment adverse effects during 24 hours after surgery such as respiratory depression, bradycardia, nausea and vomiting, and dizzy were recorded and treated accordingly. 24 hours after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT05990790 - The Effect of Desflurane Versus Sevoflurane Versus Propofol on Postoperative Delirium Phase 4
Terminated NCT03337282 - Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
Active, not recruiting NCT02965235 - Correlations of Epigenetic Changes With POCD in Surgical Patients N/A
Not yet recruiting NCT02224443 - Effects of Different Doses of Dexmedetomidine on Postoperative Cognitive Dysfunction in Elderly Hypertensive Patients Phase 4
Recruiting NCT01934049 - Postoperative Recovery in Elderly Patients Undergoing Hip Hemi-arthroplasty Phase 4
Terminated NCT00991328 - Role of Absolute Cerebral Oximetry to Prevent Neurocognitive Injury in Elderly Patients Undergoing Cardiac Surgery Phase 3
Terminated NCT00757913 - n-3 Enriched Nutrition Therapy and Postoperative Cognitive Dysfunction After Cardiac Surgery Phase 4
Terminated NCT00455143 - Cognitive Protection - Dexmedetomidine and Cognitive Reserve Phase 4
Recruiting NCT06176144 - Impact of Desflurane and Sevoflurane on Postoperative Delirium in Elderly Patients N/A
Completed NCT03620968 - Implementation of a Cognitive Training Program to Reduce the Risk of Postoperative Cognitive Dysfunction N/A
Completed NCT04701801 - Correlation of Preoperative Anxiety With Early Postoperative Cognitive Dysfunction in Breast Cancer Patients
Not yet recruiting NCT06469515 - Older People's Neurocognitive Recovery After Cardiac Surgery
Completed NCT02931877 - Comparison of Postoperative Outcome After Sevoflurane and Propofol Anaesthesia Phase 4
Not yet recruiting NCT02909413 - Comparison of Desflurane With Sevoflurane for School-age Children in Postoperative Cognitive Function N/A
Completed NCT02650687 - Optimizing Postoperative Cognition the Elderly
Not yet recruiting NCT01622452 - Post Cardiac Surgery Neurocognitive Decline: Correlations Between Neuropsychological Tests and Functional MRI Techniques N/A
Completed NCT01103752 - Postoperative Cognitive Dysfunction After Total Knee or Hip Replacement Surgery in Fast-track Set-up N/A
Completed NCT04312516 - Greek Validation of ACE III Test in Perioperative Patients
Not yet recruiting NCT05668559 - Transcranial Magnetic Stimulation and Perioperative Neurocognitive Disorders N/A
Not yet recruiting NCT05439707 - Effects of Perioperative Transauricular Vagus Nerve Electrical Stimulation on POD, POCD and CPSP N/A